Treatment strategies and biomarkers in Crohn's disease: the PROFILE trial
- PMID: 38870964
- DOI: 10.1016/S2468-1253(24)00082-7
Treatment strategies and biomarkers in Crohn's disease: the PROFILE trial
Comment in
-
Treatment strategies and biomarkers in Crohn's disease: the PROFILE trial - Authors' reply.Lancet Gastroenterol Hepatol. 2024 Jul;9(7):592-594. doi: 10.1016/S2468-1253(24)00150-X. Lancet Gastroenterol Hepatol. 2024. PMID: 38870966 No abstract available.
Comment on
-
A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn's disease (PROFILE): a multicentre, open-label randomised controlled trial.Lancet Gastroenterol Hepatol. 2024 May;9(5):415-427. doi: 10.1016/S2468-1253(24)00034-7. Epub 2024 Feb 22. Lancet Gastroenterol Hepatol. 2024. PMID: 38402895 Free PMC article. Clinical Trial.
Similar articles
-
Treatment strategies and biomarkers in Crohn's disease: the PROFILE trial.Lancet Gastroenterol Hepatol. 2024 Jul;9(7):592. doi: 10.1016/S2468-1253(24)00077-3. Lancet Gastroenterol Hepatol. 2024. PMID: 38870967 No abstract available.
-
Treatment strategies and biomarkers in Crohn's disease: the PROFILE trial.Lancet Gastroenterol Hepatol. 2024 Jul;9(7):591. doi: 10.1016/S2468-1253(24)00112-2. Lancet Gastroenterol Hepatol. 2024. PMID: 38870965 No abstract available.
-
Treatment strategies and biomarkers in Crohn's disease: the PROFILE trial.Lancet Gastroenterol Hepatol. 2024 Jul;9(7):590-591. doi: 10.1016/S2468-1253(24)00120-1. Lancet Gastroenterol Hepatol. 2024. PMID: 38870963 No abstract available.
-
Efficacy and safety of tumor necrosis factor antagonists in Crohn's disease: overview of randomized clinical studies.Rev Gastroenterol Disord. 2004;4 Suppl 3:S18-24. Rev Gastroenterol Disord. 2004. PMID: 15580149 Review.
-
One-Year Efficacy of Guselkumab Versus Advanced Therapies for the Treatment of Moderately to Severely Active Crohn's Disease: A Network Meta-Analysis.Adv Ther. 2025 Jun;42(6):2708-2727. doi: 10.1007/s12325-025-03183-x. Epub 2025 May 6. Adv Ther. 2025. PMID: 40327280 Free PMC article. Review.
Cited by
-
Tryptophan metabolites profile predict remission with dietary therapy in pediatric Crohn's disease.Therap Adv Gastroenterol. 2025 Feb 25;18:17562848251323004. doi: 10.1177/17562848251323004. eCollection 2025. Therap Adv Gastroenterol. 2025. PMID: 40012837 Free PMC article.
-
Cohort profile: the Swedish Inception Cohort in inflammatory bowel disease (SIC-IBD).BMJ Open. 2025 May 6;15(5):e099218. doi: 10.1136/bmjopen-2025-099218. BMJ Open. 2025. PMID: 40328654 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical